MDBPF (Life & Health Insurance) Stock Valuation & Fair Value Significantly overvalued
MDBPF (Life & Health Insurance) trades at a blended P/E of 23.0, about 26% above its historical normal valuation, with a forward growth estimate of 7.1% and a PEG of 3.23. Analysts' one-year estimates have been hit 88% of the time.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
Valuation flags
- Overvalued by 26%
- Overbought (RSI 100)
Verdict history
tickerseer's rating has been trading above fair value since 2026-09-19.
Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is MDBPF overvalued?
At a blended P/E of 23.0 versus its historical normal P/E of 18.2, MDBPF trades about 26% above its typical valuation, with a PEG of 3.23 on 7.1% forward growth. tickerseer currently rates it significantly overvalued.
What is MDBPF's fair value and PEG?
MDBPF trades at a blended P/E of 23.0 against a historical normal P/E of 18.2, a PEG of 3.23, and a forward growth estimate of 7.1%.
Has tickerseer's rating of MDBPF changed?
tickerseer's rating has been trading above fair value since 2026-09-19.
Industry: Life & Health Insurance. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.